Hakki Kaya1, Abuzer Coşkun2, Osman Beton3, Ali Zorlu3, Recep Kurt4, Hasan Yucel3, Hakan Gunes4, M Birhan Yılmaz3. 1. Department of Cardiology, Cumhuriyet University Medical School, Sivas, Turkey. Electronic address: drhakkikaya84@gmail.com. 2. Department of Emergency, Sivas State Hospital, Sivas, Turkey. 3. Department of Cardiology, Cumhuriyet University Medical School, Sivas, Turkey. 4. Department of Cardiology, Sivas State Hospital, Sivas, Turkey.
Abstract
BACKGROUND: There are several studies evaluating the cardiac effects of carbon monoxide (CO) poisoning during the acute period; however, the number of studies evaluating the long-term cardiac effects is limited. OBJECTIVE: The present study aimed to evaluate the effects of blood carboxyhemoglobin (COHb) levels, elevated due to CO poisoning on the long-term development of acute myocardial infarction (AMI). METHODS: This cross-sectional cohort study included a total of 1013 consecutive patients who presented to the emergency department (ED) due to CO poisoning, between January 2005 and December 2007. The diagnosis of CO poisoning was made according to the medical history and a COHb level of greater than 5%. In terms of AMI development, the patients were followed up for an average of 56 months. RESULTS: At the end of follow-up, 100 (10%) of 1013 patients experienced AMI. Carboxyhemoglobin levels at the time of poisoning were higher among those who were diagnosed with AMI compared to those who were not (55%±6% vs 30%±7%; P<.001). Using a multivariate Cox proportional hazards model with forward stepwise method, age, COHb level, CO exposure time, and smoking remained associated with an increased risk of AMI after adjustment for the variables found to be statistically significant in a univariate analysis. According to a receiver operating characteristic curve analysis, the optimal cutoff value of COHb used to predict the development of AMI was found to be greater than 45%, with 98% sensitivity and 94.1% specificity. CONCLUSION: In patients presenting to the ED with CO poisoning, COHb levels can be helpful for risk stratification in the long-term development of AMI.
BACKGROUND: There are several studies evaluating the cardiac effects of carbon monoxide (CO) poisoning during the acute period; however, the number of studies evaluating the long-term cardiac effects is limited. OBJECTIVE: The present study aimed to evaluate the effects of blood carboxyhemoglobin (COHb) levels, elevated due to CO poisoning on the long-term development of acute myocardial infarction (AMI). METHODS: This cross-sectional cohort study included a total of 1013 consecutive patients who presented to the emergency department (ED) due to CO poisoning, between January 2005 and December 2007. The diagnosis of CO poisoning was made according to the medical history and a COHb level of greater than 5%. In terms of AMI development, the patients were followed up for an average of 56 months. RESULTS: At the end of follow-up, 100 (10%) of 1013 patients experienced AMI. Carboxyhemoglobin levels at the time of poisoning were higher among those who were diagnosed with AMI compared to those who were not (55%±6% vs 30%±7%; P<.001). Using a multivariate Cox proportional hazards model with forward stepwise method, age, COHb level, CO exposure time, and smoking remained associated with an increased risk of AMI after adjustment for the variables found to be statistically significant in a univariate analysis. According to a receiver operating characteristic curve analysis, the optimal cutoff value of COHb used to predict the development of AMI was found to be greater than 45%, with 98% sensitivity and 94.1% specificity. CONCLUSION: In patients presenting to the ED with CO poisoning, COHb levels can be helpful for risk stratification in the long-term development of AMI.
Authors: Abdullah Al-Matrouk; Ali Al-Hemoud; Mohammed Al-Hasan; Yaqoub Alabouh; Amal Dashti; Haider Bojbarah Journal: Int J Environ Res Public Health Date: 2021-08-22 Impact factor: 3.390
Authors: Jason J Rose; Ling Wang; Qinzi Xu; Charles F McTiernan; Sruti Shiva; Jesus Tejero; Mark T Gladwin Journal: Am J Respir Crit Care Med Date: 2017-03-01 Impact factor: 21.405
Authors: Hamza Sunman; Tolga Çimen; Mehmet Erat; Kadriye Gayretli Yayla; Tolga Han Efe; Seda Özkan; Engin Deniz Arslan; Sadık Açıkel Journal: Turk J Emerg Med Date: 2018-07-14
Authors: Christopher Velasquez; Tye Patchana; Brian McParland; Jonathan Lovy; Ahmad Maarouf; Christopher Whitty Journal: Spartan Med Res J Date: 2017-08-24
Authors: Thomas Zoller; Elirehema H Mfinanga; Tresphory B Zumba; Peter J Asilia; Edwin M Mutabazi; David Wimmersberger; Francis Mhimbira; Frederick Haraka; Klaus Reither Journal: Environ Health Date: 2022-04-02 Impact factor: 5.984